Leukapheresis Market is expected to reach US$ 133.90 million by 2028

Leukapheresis Disposables Segment to Lead Leukapheresis Market During 2021–2028

According to our latest study on “Leukapheresis Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Application, and End User,” the market is projected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the leukapheresis market is primarily attributed to the rising number of voluntary blood donors, rising incidenc of hematologic diseases, and the surging elderly population. However, the high cost of leukapheresis obstructs the growth of the market to a certain extent.

Based on product type, the leukapheresis market is bifurcated into leukapheresis devices and leukapheresis disposables. In 2021, the leukapheresis disposables segment held a larger share of the market. However, the leukapheresis devices segment is expected to register a higher CAGR during 2021–2028.

Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT are a few leading companies operating in the leukapheresis market.

Leukapheresis Market, by Region, 2021 (%)

---

Leukapheresis Market to Grow at a CAGR of 8.7% to reach US$ 133.90 million from 2021 to 2028

Download Free Sample

---

Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

The Report Segments Leukapheresis Market as Follows:

The leukapheresis market is segmented on the basis of product type, application, and end user. Based on product type, the market is bifurcated into leukapheresis devices and leukapheresis disposables. By application, the market is bifurcated into research applications and therapeutic applications. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, blood component providers and blood centers, and hospitals and transfusion centers.

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM